Concise review: Spinal cord injuries: How could adult mesenchymal and neural crest stem cells take up the challenge

Stem Cells

Volumn 32, Issue 4, 2014, Pages 829-843

  Neirinckx, Virginie ^a   Cantinieaux, Dorothée ^a   Coste, Cécile ^a   Rogister, Bernard ^a,b,c   Franzen, Rachelle ^a   Wislet Gendebien, Sabine ^a  

^a Groupe Interdisciplinaire de Génoprotéomique Appliquée GIGA Neurosciences Unit   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Adult mesenchymal and neural crest stem cells; Cell therapy; Spinal cord injury

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CASPASE 10; CASPASE 3; CASPASE 8; CD31 ANTIGEN; CILIARY NEUROTROPHIC FACTOR; FLICE INHIBITORY PROTEIN; FREE RADICAL; GELATINASE A; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMIC ACID; GLUTATHIONE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INHIBITOR OF DIFFERENTIATION 2; LEUKEMIA INHIBITORY FACTOR; NERVE GROWTH FACTOR; NEUROTROPHIN 3; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEOCHONDROITIN SULFATE; REACTIVE OXYGEN METABOLITE; SMOOTH MUSCLE ACTIN; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN; VON WILLEBRAND FACTOR; X LINKED INHIBITOR OF APOPTOSIS;

ADIPOSE DERIVED STEM CELL; ADULT STEM CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; ASTROCYTOSIS; AXONAL INJURY; BONE MARROW STROMAL CELL; CELL MATURATION; DECIDUOUS TOOTH STEM CELL; DEMYELINATION; DENTAL PULP STEM CELL; EMBRYONIC STEM CELL; EPIDERMAL NEURAL CREST STEM CELL; EXCITOTOXIC SPINAL CORD INJURY; EXTRACELLULAR MATRIX; HEMATOPOIETIC STEM CELL; HORIZONTAL BASAL CELL; HOST CELL; HUMAN; IMMUNOMODULATION; INFLAMMATION; LAMINA PROPRIA NEURAL CREST STEM CELL; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NERVE CELL DIFFERENTIATION; NERVE FIBER DEGENERATION; NEURAL CREST STEM CELL; NEURAL STEM CELL; NEURAL STEM CELL TRANSPLANTATION; NEUROPROTECTION; NONHUMAN; OLFACTORY ENSHEATHING CELL; OLIGODENDROGLIA; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PLURIPOTENT STEM CELL; REMYELINIZATION; SCAR FORMATION; SCHWANN CELL; SKIN DERIVED PRECURSOR CELL; SPINAL CORD INJURY; UMBILICAL CORD BLOOD STEM CELL; WOUND HEALING; ANIMAL; MESENCHYMAL STROMA CELL; METABOLISM; NEURAL CREST; PATHOLOGY; SPINAL CORD INJURIES;

ADULT STEM CELLS; ANIMALS; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; NEURAL CREST; NEURAL STEM CELLS; SPINAL CORD INJURIES;

EID: 84896379368     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1579     Document Type: Article

References (112)

1. Friedenstein AJ,. Stromal mechanisms of bone marrow: Cloning in vitro and retransplantation in vivo. Haematol Blood Transfus 1980; 25: 19-29.
2. Friedenstein AJ, Deriglasova UF, Kulagina NN, et al. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol 1974; 2: 83-92.
3. Bianco P, Riminucci M, Gronthos S, et al. Bone marrow stromal stem cells: Nature, biology, and potential applications. Stem Cells 2001; 19: 180-192.
4. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147.
5. Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002; 13: 4279-4295.
6. Dellavalle A, Sampaolesi M, Tonlorenzi R, et al. Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat Cell Biol 2007; 9: 255-267.
7. Fan J, Varshney RR, Ren L, et al. Synovium-derived mesenchymal stem cells: A new cell source for musculoskeletal regeneration. Tissue Eng Part B Rev 2009; 15: 75-86.
8. Caplan AI, Correa D,. The MSC: An injury drugstore. Cell Stem Cell 2011; 9: 11-15.
9. Erices A, Conget P, Minguell JJ,. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 2000; 109: 235-242.
10. Wang HS, Hung SC, Peng ST, et al. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 2004; 22: 1330-1337.
11. Sessarego N, Parodi A, Podesta M, et al. Multipotent mesenchymal stromal cells from amniotic fluid: Solid perspectives for clinical application. Haematologica 2008; 93: 339-346.
12. Yen BL, Huang HI, Chien CC, et al. Isolation of multipotent cells from human term placenta. Stem Cells 2005; 23: 3-9.
13. Sanchez-Ramos J, Song S, Cardozo-Pelaez F, et al. Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol 2000; 164: 247-256.
14. Wislet-Gendebien S, Hans G, Leprince P, et al. Plasticity of cultured mesenchymal stem cells: Switch from nestin-positive to excitable neuron-like phenotype. Stem Cells 2005; 23: 392-402.
15. Morikawa S, Mabuchi Y, Niibe K, et al. Development of mesenchymal stem cells partially originate from the neural crest. Biochem Biophys Res Commun 2009; 379: 1114-1119.
16. Prockop DJ, Oh JY,. Medical therapies with adult stem/progenitor cells (MSCs): A backward journey from dramatic results in vivo to the cellular and molecular explanations. J Cell Biochem 2012; 113: 1460-1469.
17. Neirinckx V, Coste C, Rogister B, et al. Concise review: Adult mesenchymal stem cells, adult neural crest stem cells, and therapy of neurological pathologies: A state of play. Stem Cells Transl Med 2013; 2: 284-296.
18. Bracken MB,. Methylprednisolone in the management of acute spinal cord injuries. Med J Aust 1990; 153: 368.
19. Karamouzian S, Nematollahi-Mahani SN, Nakhaee N, et al. Clinical safety and primary efficacy of bone marrow mesenchymal cell transplantation in subacute spinal cord injured patients. Clin Neurol Neurosurg 2012; 114: 935-939.
20. Wislet-Gendebien S, Laudet E, Neirinckx V, et al. Mesenchymal stem cells and neural crest stem cells from adult bone marrow: Characterization of their surprising similarities and differences. Cell Mol Life Sci 2012; 69: 2593-2608.
21. Neirinckx V, Marquet A, Coste C, et al. Adult bone marrow neural crest stem cells and mesenchymal stem cells are not able to replace lost neurons in acute MPTP-lesioned mice. PLoS One 2013; 8: e64723.
22. Achilleos A, Trainor PA,. Neural crest stem cells: Discovery, properties and potential for therapy. Cell Res 2012; 22: 288-304.
23. Nagoshi N, Shibata S, Kubota Y, et al. Ontogeny and multipotency of neural crest-derived stem cells in mouse bone marrow, dorsal root ganglia, and whisker pad. Cell Stem Cell 2008; 2: 392-403.
24. Glejzer A, Laudet E, Leprince P, et al. Wnt1 and BMP2: Two factors recruiting multipotent neural crest progenitors isolated from adult bone marrow. Cell Mol Life Sci 2011; 68: 2101-2114.
25. Fernandes KJ, McKenzie IA, Mill P, et al. A dermal niche for multipotent adult skin-derived precursor cells. Nat Cell Biol 2004; 6: 1082-1093.
26. Toma JG, McKenzie IA, Bagli D, et al. Isolation and characterization of multipotent skin-derived precursors from human skin. Stem Cells 2005; 23: 727-737.
27. Hu YF, Zhang ZJ, Sieber-Blum M,. An epidermal neural crest stem cell (EPI-NCSC) molecular signature. Stem Cells 2006; 24: 2692-2702.
28. Kruger GM, Mosher JT, Bixby S, et al. Neural crest stem cells persist in the adult gut but undergo changes in self-renewal, neuronal subtype potential, and factor responsiveness. Neuron 2002; 35: 657-669.
29. Gronthos S, Mankani M, Brahim J, et al. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci USA 2000; 97: 13625-13630.
30. Miura M, Gronthos S, Zhao M, et al. SHED: Stem cells from human exfoliated deciduous teeth. Proc Natl Acad Sci USA 2003; 100: 5807-5812.
31. Tomita Y, Matsumura K, Wakamatsu Y, et al. Cardiac neural crest cells contribute to the dormant multipotent stem cell in the mammalian heart. J Cell Biol 2005; 170: 1135-1146.
32. Widera D, Zander C, Heidbreder M, et al. Adult palatum as a novel source of neural crest-related stem cells. Stem Cells 2009; 27: 1899-1910.
33. Yoshida S, Shimmura S, Nagoshi N, et al. Isolation of multipotent neural crest-derived stem cells from the adult mouse cornea. Stem Cells 2006; 24: 2714-2722.
34. Barraud P, Seferiadis AA, Tyson LD, et al. Neural crest origin of olfactory ensheathing glia. Proc Natl Acad Sci USA 2010; 107: 21040-21045.
35. Suzuki J, Yoshizaki K, Kobayashi T, et al. Neural crest-derived horizontal basal cells as tissue stem cells in the adult olfactory epithelium. Neurosci Res 2013; 75: 112-120.
36. Tome M, Lindsay SL, Riddell JS, et al. Identification of nonepithelial multipotent cells in the embryonic olfactory mucosa. Stem Cells 2009; 27: 2196-2208.
37. Mujtaba T, Mayer-Proschel M, Rao MS,. A common neural progenitor for the CNS and PNS. Dev Biol 1998; 200: 1-15.
38. Sieber-Blum M, Hu Y,. Epidermal neural crest stem cells (EPI-NCSC) and pluripotency. Stem Cell Rev 2008; 4: 256-260.
39. Lee BB, Cripps RA, Fitzharris M, et al. The global map for traumatic spinal cord injury epidemiology: Update 2011, global incidence rate. Spinal Cord 2013 [Epub ahead of print], doi: 10.1038/sc.2012.158.
40. Spinal cord injury facts and figures at a glance. J Spinal Cord Med 2012; 35: 480-481.
41. Oyinbo CA,. Secondary injury mechanisms in traumatic spinal cord injury: A nugget of this multiply cascade. Acta Neurobiol Exp (Wars) 2011; 71: 281-299.
42. Ronaghi M, Erceg S, Moreno-Manzano V, et al. Challenges of stem cell therapy for spinal cord injury: Human embryonic stem cells, endogenous neural stem cells, or induced pluripotent stem cells Stem Cells 2010; 28: 93-99.
43. Caplan AI, Dennis JE,. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006; 98: 1076-1084.
44. Phinney DG, Hill K, Michelson C, et al. Biological activities encoded by the murine mesenchymal stem cell transcriptome provide a basis for their developmental potential and broad therapeutic efficacy. Stem Cells 2006; 24: 186-198.
45. Fuhrmann T, Montzka K, Hillen LM, et al. Axon growth-promoting properties of human bone marrow mesenchymal stromal cells. Neurosci Lett 2010; 474: 37-41.
46. Voulgari-Kokota A, Fairless R, Karamita M, et al. Mesenchymal stem cells protect CNS neurons against glutamate excitotoxicity by inhibiting glutamate receptor expression and function. Exp Neurol 2012; 236: 161-170.
47. Crigler L, Robey RC, Asawachaicharn A, et al. Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp Neurol 2006; 198: 54-64.
48. Zhou Z, Chen Y, Zhang H, et al. Comparison of mesenchymal stromal cells from human bone marrow and adipose tissue for the treatment of spinal cord injury. Cytotherapy 2013; 15: 434-448.
49. Sasaki M, Radtke C, Tan AM, et al. BDNF-hypersecreting human mesenchymal stem cells promote functional recovery, axonal sprouting, and protection of corticospinal neurons after spinal cord injury. J Neurosci 2009; 29: 14932-14941.
50. Quertainmont R, Cantinieaux D, Botman O, et al. Mesenchymal stem cell graft improves recovery after spinal cord injury in adult rats through neurotrophic and pro-angiogenic actions. PLoS One 2012; 7: e39500.
51. Hawryluk GW, Mothe A, Wang J, et al. An in vivo characterization of trophic factor production following neural precursor cell or bone marrow stromal cell transplantation for spinal cord injury. Stem Cells Dev 2012; 21: 2222-2238.
52. Bartholomew A, Sturgeon C, Siatskas M, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002; 30: 42-48.
53. Jiang XX, Zhang Y, Liu B, et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 2005; 105: 4120-4126.
54. Aggarwal S, Pittenger MF,. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005; 105: 1815-1822.
55. Spaggiari GM, Capobianco A, Becchetti S, et al. Mesenchymal stem cell-natural killer cell interactions: Evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 2006; 107: 1484-1490.
56. Le Blanc K, Rasmusson I, Sundberg B, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004; 363: 1439-1441.
57. Uccelli A, Moretta L, Pistoia V,. Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008; 8: 726-736.
58. Prockop DJ, Oh JY,. Mesenchymal stem/stromal cells (MSCs): Role as guardians of inflammation. Mol Ther 2012; 20: 14-20.
59. Singer NG, Caplan AI,. Mesenchymal stem cells: Mechanisms of inflammation. Annu Rev Pathol 2011; 6: 457-478.
60. Abrams MB, Dominguez C, Pernold K, et al. Multipotent mesenchymal stromal cells attenuate chronic inflammation and injury-induced sensitivity to mechanical stimuli in experimental spinal cord injury. Restor Neurol Neurosci 2009; 27: 307-321.
61. Yalvac ME, Yarat A, Mercan D, et al. Characterization of the secretome of human tooth germ stem cells (hTGSCs) reveals neuro-protection by fine-tuning micro-environment. Brain Behav Immun 2013; 32: 122-130.
62. Kim WS, Park BS, Kim HK, et al. Evidence supporting antioxidant action of adipose-derived stem cells: Protection of human dermal fibroblasts from oxidative stress. J Dermatol Sci 2008; 49: 133-142.
63. Oh JS, Kim KN, An SS, et al. Cotransplantation of mouse neural stem cells (mNSCs) with adipose tissue-derived mesenchymal stem cells improves mNSC survival in a rat spinal cord injury model. Cell Transplant 2011; 20: 837-849.
64. Isele NB, Lee HS, Landshamer S, et al. Bone marrow stromal cells mediate protection through stimulation of PI3-K/Akt and MAPK signaling in neurons. Neurochem Int 2007; 50: 243-250.
65. Busch SA, Hamilton JA, Horn KP, et al. Multipotent adult progenitor cells prevent macrophage-mediated axonal dieback and promote regrowth after spinal cord injury. J Neurosci 2011; 31: 944-953.
66. Seo JH, Jang IK, Kim H, et al. Early immunomodulation by intravenously transplanted mesenchymal stem cells promotes functional recovery in spinal cord injured rats. Cell Med 2011; 2: 55-67.
67. Nakajima H, Uchida K, Guerrero AR, et al. Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury. J Neurotrauma 2012; 29: 1614-1625.
68. Lin WP, Chen XW, Zhang LQ, et al. Effect of neuroglobin genetically modified bone marrow mesenchymal stem cells transplantation on spinal cord injury in rabbits. PLoS One 2013; 8: e63444.
69. Dasari VR, Spomar DG, Cady C, et al. Mesenchymal stem cells from rat bone marrow downregulate caspase-3-mediated apoptotic pathway after spinal cord injury in rats. Neurochem Res 2007; 32: 2080-2093.
70. Kigerl KA, Gensel JC, Ankeny DP, et al. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 2009; 29: 13435-13444.
71. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41-49.
72. Hall ED,. Antioxidant therapies for acute spinal cord injury. Neurotherapeutics 2011; 8: 152-167.
73. Valle-Prieto A, Conget PA,. Human mesenchymal stem cells efficiently manage oxidative stress. Stem Cells Dev 2010; 19: 1885-1893.
74. Ko E, Lee KY, Hwang DS,. Human umbilical cord blood-derived mesenchymal stem cells undergo cellular senescence in response to oxidative stress. Stem Cells Dev 2012; 21: 1877-1886.
75. Crowe MJ, Bresnahan JC, Shuman SL, et al. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat Med 1997; 3: 73-76.
76. Yu WR, Liu T, Fehlings TK, et al. Involvement of mitochondrial signaling pathways in the mechanism of Fas-mediated apoptosis after spinal cord injury. Eur J Neurosci 2009; 29: 114-131.
77. Nakahara S, Yone K, Sakou T, et al. Induction of apoptosis signal regulating kinase 1 (ASK1) after spinal cord injury in rats: Possible involvement of ASK1-JNK and -p38 pathways in neuronal apoptosis. J Neuropathol Exp Neurol 1999; 58: 442-450.
78. Dasari VR, Veeravalli KK, Tsung AJ, et al. Neuronal apoptosis is inhibited by cord blood stem cells after spinal cord injury. J Neurotrauma 2009; 26: 2057-2069.
79. Dasari VR, Spomar DG, Li L, et al. Umbilical cord blood stem cell mediated downregulation of fas improves functional recovery of rats after spinal cord injury. Neurochem Res 2008; 33: 134-149.
80. Steffenhagen C, Dechant FX, Oberbauer E, et al. Mesenchymal stem cells prime proliferating adult neural progenitors toward an oligodendrocyte fate. Stem Cells Dev 2012; 21: 1838-1851.
81. Rivera FJ, Couillard-Despres S, Pedre X, et al. Mesenchymal stem cells instruct oligodendrogenic fate decision on adult neural stem cells. Stem Cells 2006; 24: 2209-2219.
82. Rivera FJ, Siebzehnrubl FA, Kandasamy M, et al. Mesenchymal stem cells promote oligodendroglial differentiation in hippocampal slice cultures. Cell Physiol Biochem 2009; 24: 317-324.
83. Rivera FJ, Kandasamy M, Couillard-Despres S, et al. Oligodendrogenesis of adult neural progenitors: Differential effects of ciliary neurotrophic factor and mesenchymal stem cell derived factors. J Neurochem 2008; 107: 832-843.
84. Lindsay SL, Johnstone SA, Mountford JC, et al. Human mesenchymal stem cells isolated from olfactory biopsies but not bone enhance CNS myelination in vitro. Glia 2013; 61: 368-382.
85. Zhang YJ, Zhang W, Lin CG, et al. Neurotrophin-3 gene modified mesenchymal stem cells promote remyelination and functional recovery in the demyelinated spinal cord of rats. J Neurol Sci 2012; 313: 64-74.
86. Park SI, Lim JY, Jeong CH, et al. Human umbilical cord blood-derived mesenchymal stem cell therapy promotes functional recovery of contused rat spinal cord through enhancement of endogenous cell proliferation and oligogenesis. J Biomed Biotechnol 2012; 2012: 362473.
87. Biernaskie J, Sparling JS, Liu J, et al. Skin-derived precursors generate myelinating Schwann cells that promote remyelination and functional recovery after contusion spinal cord injury. J Neurosci 2007; 27: 9545-9559.
88. Kamada T, Koda M, Dezawa M, et al. Transplantation of human bone marrow stromal cell-derived Schwann cells reduces cystic cavity and promotes functional recovery after contusion injury of adult rat spinal cord. Neuropathology 2011; 31: 48-58.
89. Xu X, Geremia N, Bao F, et al. Schwann cell coculture improves the therapeutic effect of bone marrow stromal cells on recovery in spinal cord-injured mice. Cell Transplant 2011; 20: 1065-1086.
90. Veeravalli KK, Dasari VR, Tsung AJ, et al. Human umbilical cord blood stem cells upregulate matrix metalloproteinase-2 in rats after spinal cord injury. Neurobiol Dis 2009; 36: 200-212.
91. Zhang H, Chang M, Hansen CN, et al. Role of matrix metalloproteinases and therapeutic benefits of their inhibition in spinal cord injury. Neurotherapeutics 2011; 8: 206-220.
92. Duchossoy Y, Horvat JC, Stettler O,. MMP-related gelatinase activity is strongly induced in scar tissue of injured adult spinal cord and forms pathways for ingrowing neurites. Mol Cell Neurosci 2001; 17: 945-956.
93. Hsu JY, McKeon R, Goussev S, et al. Matrix metalloproteinase-2 facilitates wound healing events that promote functional recovery after spinal cord injury. J Neurosci 2006; 26: 9841-9850.
94. Oh JS, Park IS, Kim KN, et al. Transplantation of an adipose stem cell cluster in a spinal cord injury. Neuroreport 2012; 23: 277-282.
95. Zeng X, Zeng YS, Ma YH, et al. Bone marrow mesenchymal stem cells in a three-dimensional gelatin sponge scaffold attenuate inflammation, promote angiogenesis, and reduce cavity formation in experimental spinal cord injury. Cell Transplant 2011; 20: 1881-1899.
96. Lukovic D, Moreno Manzano V, Stojkovic M, et al. Concise review: Human pluripotent stem cells in the treatment of spinal cord injury. Stem Cells 2012; 30: 1787-1792.
97. Nakamura M, Okano H,. Cell transplantation therapies for spinal cord injury focusing on induced pluripotent stem cells. Cell Res 2013; 23: 70-80.
98. Joyce N, Annett G, Wirthlin L, et al. Mesenchymal stem cells for the treatment of neurodegenerative disease. Regen Med 2010; 5: 933-946.
99. Uccelli A, Laroni A, Freedman MS,. Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases. Lancet Neurol 2011; 10: 649-656.
100. Wright KT, El Masri W, Osman A, et al. Concise review: Bone marrow for the treatment of spinal cord injury: Mechanisms and clinical applications. Stem Cells 2011; 29: 169-178.
101. Mothe AJ, Tator CH,. Advances in stem cell therapy for spinal cord injury. J Clin Invest 2012; 122: 3824-3834.
102. Gogel S, Gubernator M, Minger SL,. Progress and prospects: Stem cells and neurological diseases. Gene Ther 2011; 18: 1-6.
103. Tetzlaff W, Okon EB, Karimi-Abdolrezaee S, et al. A systematic review of cellular transplantation therapies for spinal cord injury. J Neurotrauma 2011; 28: 1611-1682.
104. Ra JC, Shin IS, Kim SH, et al. Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. Stem Cells Dev 2011; 20: 1297-1308.
105. Pal R, Venkataramana NK, Bansal A, et al. Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: A pilot clinical study. Cytotherapy 2009; 11: 897-911.
106. Cantinieaux D, Quertainmont R, Blacher S, et al. Conditioned medium from bone marrow-derived mesenchymal stem cells improves recovery after spinal cord injury in rats: An original strategy to avoid cell transplantation. PLoS One 2013; 8: e69515.
107. Wang J, Liao L, Wang S, et al. Cell therapy with autologous mesenchymal stem cells-How the disease process impacts clinical considerations. Cytotherapy 2013; 15: 893-904.
108. Brohlin M, Kingham PJ, Novikova LN, et al. Aging effect on neurotrophic activity of human mesenchymal stem cells. PLoS One 2012; 7: e45052.
109. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315-317.
110. Shin DA, Kim JM, Kim HI, et al. Comparison of functional and histological outcomes after intralesional, intracisternal, and intravenous transplantation of human bone marrow-derived mesenchymal stromal cells in a rat model of spinal cord injury. Acta Neurochir (Wien) 2013; 155: 1943-1950.
111. Kim JW, Ha KY, Molon JN, et al. Bone marrow-derived mesenchymal stem cell transplantation for chronic spinal cord injury in rats: Comparative study between intralesional and intravenous transplantation. Spine (Phila Pa 1976) 2013; 38: E1065-1074.
112. Vawda R, Fehlings MG,. Mesenchymal cells in the treatment of spinal cord injury: Current & future perspectives. Curr Stem Cell Res Ther 2013; 8: 25-38.